MedPath

BHCG Level in Day 4,7, in Comparison to Day 10 as an Indicator for Treatment Success

Phase 4
Conditions
Ectopic Pregnancy
Interventions
Registration Number
NCT01860690
Lead Sponsor
Meir Medical Center
Brief Summary

The investigators want to compeer BHCG levels after Methotrexate ( MTX). treatment for Ectopic pregnancy in days 4 and 7 after MTX. to day 10 . The hypothesis is that "BHCG" level in day 10 is the best indicator for treatment success , superior to day 4 and 7 . According to the investigators impression BHCG level rises in days 4 and 7 due to destruction of the trophoblast tissue , and only day 10 is an indicator for treatment success

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • patients with ectopic pregnancy
  • healthy
  • hemodynamic stable
  • first ectopic
Exclusion Criteria
  • hemodynamic non-stable
  • abnormal liver or kidney function
  • allergy reaction to MTX

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
MTX , treatment outcomeMethotrexatepatient receiving MTX. in a dosage of 50 mg/m\^2 , IM , in single dose
Primary Outcome Measures
NameTimeMethod
To measure the change of levels of "BHCG" in patients receiving Methotrexate for treatment of ectopic pregnancy in days 4, 7, and 10 post treatmentthe change of levels in days 4, 7, and 10 post MTX injection

To compeer levels of BHCG in days 4 and 7 to day 10 after injection of MTX. for Ectopic pregnancy treatment

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Dr. Zvi Klein

🇮🇱

Kefar-saba, Israel

© Copyright 2025. All Rights Reserved by MedPath